Related by context. All words. (Click for frequent words.) 75 Glybera R 66 Phase IIb clinical trials 66 MAA submission 66 Aryplase 66 inhaled AAT 66 ruxolitinib 66 Panzem R 66 INCB# [001] 66 Firazyr 65 registrational 65 histamine dihydrochloride 65 Onconase 65 SNT MC# 65 generation purine nucleoside 65 Cimzia ® certolizumab pegol 65 Evoltra ® 64 BLA filing 64 Saforis 64 AZILECT ® 64 UPLYSO 64 OvaRex ® MAb 64 Phase 1a clinical 64 Cimzia TM 64 Quinamed 64 Plicera 64 Icatibant 64 omacetaxine mepesuccinate 64 liposomal formulation 64 product Glybera R 64 phase IIa clinical 64 PLK1 SNALP 64 Phenoptin 64 AZILECT R 64 Anavex #-# 64 Pivotal Phase III 64 Phase IIb trials 64 vosaroxin 64 ANTEGREN 64 tafamidis 63 acyclovir Lauriad R 63 Huntexil 63 Phase Ib study 63 Alvesco R 63 Esbriet ® 63 Camvia 63 KNS # 63 PDE4 inhibitor 63 ataluren 63 Phase IIIb clinical 63 liprotamase 63 PREOS 63 brivaracetam 63 refractory chronic lymphocytic 63 Dalbavancin 63 Catena ® 63 Trobalt 63 Urocortin 2 63 YONDELIS 63 Fx #A 63 oral prodrug 63 vidofludimus 63 Soliris eculizumab 63 XYOTAX TM 63 Zenvia ™ 63 forodesine 63 oral salmon calcitonin 63 thetreatment 63 ZYBRESTAT TM 63 intranasal formulation 63 Evoltra 63 OvaRex R 63 Alzhemed TM 63 molecular imaging radiopharmaceutical 63 PI3K/Akt pathway inhibitor 63 Bendamustine 63 PNP inhibitor 63 ATPace TM 63 Egrifta 63 FRDA 63 Phase #b/#a clinical 63 Junovan TM 63 IPLEX 63 successfully commercialize Iluvien 63 orBec 63 Biologic License Application BLA 62 hoFH 62 MAGE A3 ASCI 62 ARIKACE ™ 62 Corlux 62 Phase #b/#a 62 FOLOTYN ® 62 Teysuno 62 ELIQUIS 62 antibody MAb 62 IMA# 62 confirmatory Phase III 62 #D#C# 62 PD LID 62 GALNS 62 Azedra 62 JAK inhibitor 62 Asentar 62 GATTEX ® 62 PDX pralatrexate 62 orphan designation 62 HQK 62 GAMMAGARD 62 Cloretazine ® 62 PANVAC VF 62 HuMax EGFr 62 Prosaptide 62 Dyloject TM 62 acyclovir Lauriad ® 62 octreotide implant 62 TELINTRA 62 trastuzumab DM1 T DM1 62 TOLAMBA 62 Vidaza azacitidine 62 HuMax CD4 62 tezampanel NGX# 62 TBC# 62 multicenter Phase II 62 severe hypercholesterolemia 62 Vidaza R 62 phase IIb clinical 62 RIGScan CR 62 Orathecin 62 histone deacetylase HDAC inhibitor 62 Temsirolimus 62 docetaxel Taxotere ® 62 Solazed 62 Anturol TM 62 phase IIa 62 Troxatyl 62 NPSP# 62 alemtuzumab Campath 62 novel oral anticoagulant 62 Bezielle 62 Arranon 62 HoFH 62 Voraxaze 62 histone deacetylase inhibitor 62 Zenpep 62 Somatuline R Autogel R 62 Altropane 62 ADVEXIN 62 Fodosine 62 Keppra XR 62 sargramostim 62 ASONEP 62 Ceflatonin 62 mertansine 62 epoetin alpha 62 ganaxolone 62 Spiegelmer ® 62 ELACYT 62 YONDELIS R 62 reslizumab 62 Nexavar ® 62 HuMax 62 REBETOL combination therapy 62 Troxatyl TM 62 anticancer compound 61 Esbriet pirfenidone 61 BAY #-# 61 HuLuc# 61 Marqibo TM 61 incyclinide 61 Tarceva TM 61 BrachySil TM 61 OMAPRO ™ 61 Rescula 61 SNS# T 61 orally administered inhibitor 61 Xcellerated T Cells 61 Oracea TM 61 VIAject R 61 PHX# 61 TOCOSOL 61 acetonide FA 61 LPLD 61 PrevOnco ™ 61 Raptiva R 61 bazedoxifene 61 Arzerra TM 61 NeuroSTAT ® 61 OncoVEX 61 Archexin 61 docetaxel Taxotere R 61 Receives Orphan Drug Designation 61 Granulocyte Colony Stimulating Factor 61 LEVADEX ™ 61 Files Investigational 61 CA9 SCAN 61 R#/MEM 61 Vectibix panitumumab 61 Safinamide 61 Bonefos 61 Omacetaxine 61 r hGH 61 ALN TTR# 61 BRILINTA 61 virus HCV protease inhibitor 61 Rhucin R 61 Marketing Authorisation Application MAA 61 Increlex R 61 somatostatin analogue 61 isoform selective 61 SPRYCEL ® 61 Ketotransdel 61 FIRMAGON R 61 fosbretabulin 61 novel prodrug 61 PREOS R 61 hyaluronidase enzyme 61 lorvotuzumab mertansine 61 Phase 2a clinical trials 61 Yondelis ® 61 GLP toxicology studies 61 CD# CEA 61 aurora kinase 61 Allovectin 7 61 CEQ# 61 ICA # 61 nonclinical studies 61 MOZOBIL 61 novel histone deacetylase 61 Marketing Authorisation Application 61 LAF# 61 ONCONASE R 61 OncoGel 61 targeted radiotherapeutic 61 LUMINATE 61 pain palliation 61 CVac 61 Rhucin ® 61 Dual Opioid 61 Retacrit 61 Removab 61 TH# [003] 61 EVIZON TM 61 oral taxane 61 RhuDex ® 61 corticosteroid dexamethasone 61 Betaseron ® 61 JZP 61 amifampridine phosphate 61 ACCLAIM II 61 pharmacokinetic PK study 61 trodusquemine 61 Valtropin 61 DCCR 61 ONGLYZA ™ 61 IL# PE#QQR 61 Junovan 61 midstage trials 61 Amigal 61 OVATURE 61 rotigotine transdermal patch 61 PTK# 61 REMINYL ® 61 Exelon Patch 61 TKM ApoB 61 TLK# 61 Alferon N 61 Laquinimod 61 Inhalation Solution 61 humanised monoclonal antibody 61 prucalopride 61 ® natalizumab 61 TELCYTA 61 Arikace 61 Civacir 61 Onrigin 61 vemurafenib 61 sorafenib tablets 61 Phase IIB 61 Initiates Phase III 61 BLA submission 60 QNEXA 60 MEK inhibitor 60 Fabry Disease 60 Aplidin 60 TRO# 60 Cloretazine R 60 StemEx 60 PMA submission 60 RAPTIVA 60 ALN HPN 60 ONCASPAR 60 BENLYSTA ® 60 ISTODAX 60 L BLP# 60 Panzem NCD 60 proteasome inhibitor 60 pralatrexate 60 preclinical efficacy 60 Bicifadine 60 EndoTAG TM 60 teduglutide 60 neratinib 60 Personalized Immunotherapy 60 rhIGF-I/rhIGFBP-3 60 Genz # 60 SUTENT ® 60 GW# [003] 60 Phase Ib clinical 60 Arcalyst 60 VitiGam 60 receptor tyrosine kinase inhibitor 60 oral methylnaltrexone 60 G#DT 60 Phase #/#a trial 60 PRT# 60 Solorel 60 tramiprosate Alzhemed TM 60 Ereska 60 EGS# 60 aleglitazar 60 cystinosis patients 60 Somatuline R Depot 60 MK #B 60 Saxagliptin 60 Actimmune ® 60 investigational humanized monoclonal antibody 60 ALN PCS 60 Marketing Authorization Application 60 maximally tolerated dose 60 Hexvix ® 60 HDAC Inhibitor 60 StemEx R 60 Orphan Drug status 60 ganetespib 60 Immunotherapeutic 60 relapsing multiple sclerosis 60 Cellegesic 60 Dacogen injection 60 preclinical pharmacokinetic 60 Entereg R 60 Urocidin 60 phase IIIb 60 Febuxostat 60 NEBIDO 60 AMD# [003] 60 Xanafide 60 budesonide MMX 60 SANVAR 60 Genasense ® oblimersen 60 LymphoStat B TM 60 antibody MT# 60 LibiGel ® 60 Soliris TM eculizumab 60 PROVENGE ® 60 bicifadine 60 Tyrima 60 vivo validation 60 Targretin capsules 60 sNDA submission 60 HDL Selective Delipidation 60 Neovasc Reducer 60 alvespimycin 60 Lenocta 60 LPL deficiency 60 HFA MDI 60 CTAP# Capsules 60 Aviptadil 60 Panzem 60 Initiate Clinical Trial 60 TRISENOX 60 Kuvan 60 Lodotra 60 Presents Preclinical 60 interferon gamma 1b 60 TREDAPTIVE 60 RSR# 60 Peginterferon alfa 2b 60 BEMA TM Fentanyl 60 Pafuramidine 60 Phase #b/#a trial 60 THR beta agonist 60 immunotherapeutic vaccine 60 BAL# [002] 60 dextromethorphan quinidine 60 GLP1 INT TM 60 Nebido 60 Phase Ib IIa 60 CRMD# 60 registrational trial 60 lumiliximab 60 phase IIb study 60 ZOLINZA 60 intravenous acetaminophen 60 Premarket Approval Application 60 Squalamine 60 Ceflatonin R 60 Ruconest 60 Entereg TM 60 vascular disrupting agents 60 PEGylated interferon beta 1a 60 Zorbtive TM 60 PEG SN# 60 NP2 Enkephalin 60 casopitant 60 Vilazodone 60 Mepact 60 balsalazide tablet 60 Insegia 60 Loramyc R 60 tiapamil 60 HepeX B 60 Iloperidone 60 LEUKINE 60 Trofex 60 Mipomersen 60 Advagraf 60 SinuNase ™ 60 Pyridorin 60 R#/MEM # 60 ENTEREG ® 60 ORENCIA ® 60 tanespimycin 60 Chemophase 60 SAR# [002] 60 Clolar ® 60 Tykerb lapatinib 60 CoFactor 60 Extina 60 TroVax ® 60 IIa trials 60 VNP#M 60 mGluR2 NAM 59 Anticalin ® 59 mda 7 59 TRX1 59 Phase III Clinical Trial 59 dasatinib Sprycel 59 alemtuzumab MS 59 Perforomist ™ Inhalation Solution 59 omacetaxine 59 Factor VIIa 59 assessing T DM1 59 obatoclax 59 alvimopan 59 Phase IIb III 59 thalidomide Thalomid 59 Cloretazine 59 Benlysta belimumab 59 epigenetic therapies 59 JAK3 inhibitor 59 MAXY G# 59 CCR5 mAb 59 OPAXIO 59 pegfilgrastim 59 cetuximab Erbitux R 59 Phase III multicenter 59 rasagiline tablets 59 Prestara TM 59 oral ridaforolimus 59 PrevOnco 59 Initiates Phase II 59 oxybutynin topical gel 59 AMPK activators 59 Marqibo 59 targeted antifolate 59 Initiates Clinical 59 aclidinium bromide 59 Noxafil 59 Phase III confirmatory 59 phase Ib clinical 59 Centralized Procedure 59 adecatumumab MT# 59 ToGA 59 TASKi3 59 ponatinib 59 Cloretazine R VNP#M 59 Serdolect ® 59 octreotide acetate 59 ridaforolimus 59 apoptosis inducer 59 sitaxsentan 59 cetuximab Erbitux 59 metastatic malignant 59 urocortin 2 59 synthetic retinoid 59 XmAb# 59 AeroLEF TM 59 XL# anticancer compounds 59 optimal dosing regimens 59 canakinumab 59 AAG geldanamycin analog 59 PSMA ADC 59 rALLy trial 59 Entocort 59 PROMACTA 59 Luveniq 59 Stimuvax R 59 Vitaxin 59 exon skipping 59 Preclinical studies suggest 59 Panzem R NCD 59 Solazed TM 59 Pirfenidone 59 Tasimelteon 59 deforolimus 59 Premarket Approval 59 telaprevir VX 59 Diamyd r 59 MGd 59 Prodarsan R 59 Iluvien ® 59 RhuDex 59 Panzem ® 59 phase III isavuconazole 59 miconazole Lauriad R 59 CB2 selective receptor agonist 59 Specifid 59 Exelixis compounds 59 microtubule inhibitor 59 Phase IIa trials 59 telomerase inhibitor drug 59 R sorafenib tablets 59 BioSTAR ® 59 Combidex 59 somatostatin analogues 59 Zalbin 59 MGCD# [001] 59 Sanvar R 59 Vernakalant 59 investigational antiplatelet agent 59 AERx iDMS 59 investigational therapies 59 Kamada AAT 59 PEGylated anti 59 ALN TTR 59 Bazedoxifene 59 Maribavir 59 VALOR trial 59 RhuDex TM 59 MNTX 59 PDE# inhibitors 59 pancreatic enzyme replacement 59 novel VDA molecule 59 Ambrisentan 59 LUVENIQ 59 induced macular edema 59 sunitinib malate 59 Cetrorelix 59 eprotirome 59 rxRNA 59 Rebif ® 59 Prodarsan ® 59 GMX# 59 ELND# 59 Ceplene TM 59 orally bioavailable 59 diabetic neuropathic pain 59 Orphan Drug designations 59 gefitinib Iressa 59 RELOVAIR ™ 59 axitinib 59 small molecule tyrosine 59 omega interferon 59 CIP TRAMADOL ER 59 NV1FGF 59 lintuzumab SGN 59 CORT # 59 Sprycel dasatinib 59 TOCOSOL Paclitaxel 59 NEUVENGE 59 HCD# [002] 59 volociximab 59 pemetrexed Alimta 59 APEX PD 59 BioSTAR R 59 inhaled iloprost 59 Evoltra R 59 AMD# [002] 59 Anturol 59 Phase III HEAT 59 Prestara 59 MYLOTARG 59 EndoTAG TM -1 59 Ophena TM 59 Phase III Clinical Trials 59 Frova ® 59 OMAPRO 59 Tanespimycin 59 entinostat 59 romidepsin 59 DURIN TM 59 Xyfid TM 59 Triolex 59 AP# [003] 59 QNEXA ® 59 CLARITY study 59 IMC #B 59 BARACLUDE R 59 sirtuin modulators 59 JAK2 inhibitor 59 Pruvel 59 Phase 2b kidney transplant 59 Onbrez Breezhaler 59 Plenaxis TM 59 Surfaxin LS 59 Eloxatin ® 59 XP# XP# 59 Viprinex TM 59 pharmacokinetic PK profile 59 Phase 2a trial 59 TASKi2 59 Telintra 59 Androxal TM 59 highly selective inhibitor 59 selective androgen receptor modulator 59 selective modulator 59 lexidronam injection 59 GATTEX ™ 59 intranasal delivery 59 DermaVir Patch 59 Deforolimus 59 UVIDEM 59 M Vax 59 Guanilib 59 IND CTA 59 HepaSphere 59 Altastaph 59 Gleevec Glivec 59 Degarelix 59 Nasdaq PPHM 59 selective adenosine 59 Leukine ® 59 vascular disrupting agent 59 TransVax tm 59 squalamine 59 CCX# 59 STRIDE PD 59 NVA# 59 ONTAK 59 afamelanotide 59 guanfacine extended release 59 Acetavance TM 59 Velcade bortezomib 59 uricase 59 Bioral ® 59 CAPHOSOL 59 malignant ascites 59 Certican 59 HCV protease inhibitors 59 non nucleoside inhibitor 59 Betaferon R 59 MGCD# clinical trials 59 Cethrin 59 pentostatin 59 MAXY VII 59 phase IIb 59 Romidepsin 59 huN# DM1 59 Xcytrin R 59 Phase 1b trial 59 Golimumab 59 tubulin inhibitor 59 BrachySil 59 nalbuphine ER 59 CCR5 antagonist 59 Octreolin 59 ITAX 59 MEPACT 59 Onalta ™ 59 tramiprosate 59 cannabinor 59 SCIB1 58 pediatric acute lymphoblastic 58 Campath ® 58 Zemplar Capsules 58 Campath alemtuzumab 58 ProSavin 58 subcutaneous formulation 58 Morquio 58 glucokinase activator 58 IMiDs 58 Telatinib 58 mitogen activated ERK kinase 58 Phase Ib II 58 ALGRX 58 Psoraxine R 58 drug GAP #B# 58 Aurexis 58 Omapro 58 preclinically 58 Orally administered 58 Syncria 58 BRIM2 58 Orencia abatacept 58 Initiate Phase 58 BCX# 58 Amrubicin 58 OMP designation 58 ospemifene 58 NEUPREX R 58 regorafenib 58 Phase IIa clinical 58 cysteamine bitartrate 58 GVAX ® 58 desvenlafaxine 58 Plenaxis R 58 RoACTEMRA 58 inhibitor RG# 58 initiate Phase IIa 58 Zybrestat 58 IAP inhibitors 58 NADiA ProsVue 58 ZEVALIN ® 58 Anturol ® 58 desvenlafaxine succinate 58 Oncotype DX colon cancer 58 Fludara ® 58 ixabepilone 58 TRIST study 58 novel therapeutic antibodies 58 Abiraterone acetate 58 Multiple Ascending Dose 58 Triapine R 58 rilonacept 58 tamibarotene 58 interferon beta 1b 58 lomitapide 58 ularitide 58 ApoB SNALP 58 Completes Patient Enrollment 58 Sanctura XR 58 RezularTM 58 Vandetanib 58 AzaSite Plus 58 seliciclib CYC# 58 Romiplostim 58 atacicept 58 Dasatinib 58 JAK inhibitors 58 Aflunov 58 Preotact 58 peginesatide 58 immatics 58 beta 1a 58 radiation sensitizer 58 MEND CABG II 58 MIRCERA 58 Angiocept 58 GSK# [001] 58 telomerase therapeutic 58 IRX 2 58 oritavancin 58 Phase IIa trial 58 SinuNase TM 58 cytokine refractory 58 lapatinib Tykerb 58 Poly ICLC 58 Thorough QT 58 Cancidas 58 EOquin TM 58 KRN# 58 OHR/AVR# 58 MIST II 58 oral FTY# 58 Zerenex ™ 58 Ataluren 58 investigational oral hepatitis C 58 Raptiva ® 58 Proxinium TM 58 Onalta 58 CINOD 58 HCV protease inhibitor 58 Serdolect 58 Friedreich Ataxia FRDA 58 HyperAcute 58 multicenter Phase III 58 BCR ABL inhibitor 58 bortezomib Velcade 58 miconazole Lauriad ® 58 Tezampanel 58 CDP# 58 PRECISE trial 58 tezampanel 58 Pivotal Phase 58 ARCOXIA 58 IV APAP 58 ILUVIEN ® 58 IND submission 58 MyVax R 58 Geron telomerase inhibitor 58 thorough QT 58 Zelrix 58 Nuvion 58 Capesaris 58 monoclonal anti 58 anti angiogenic agent 58 Achieves Primary Endpoint 58 VITAL Trial 58 PFO migraine 58 Nexavar sorafenib 58 Drug Eluting Stent System 58 Dendreon Provenge 58 Allovectin 7 R 58 preclinical pharmacology 58 JVRS 58 methylnaltrexone bromide 58 radiolabelled 58 ATIR 58 teriflunomide 58 Polymer Microspheres 58 HGS# 58 Ceflatonin ® 58 Phase 2b clinical trials 58 LentiVector 58 Zarnestra 58 Alequel ™ 58 Allovectin 7 r 58 HGS ETR2 58 HCV protease 58 ZEGERID Capsules 58 Successfully Completes Phase 58 Erbitux cetuximab 58 DCVax R 58 T Pred 58 pan HDAC inhibitor 58 Omnitarg 58 TPI ASM8 58 motexafin gadolinium Injection 58 oral PTH 58 efaproxiral 58 Rasagiline 58 CIMZIA TM 58 Natalizumab 58 CINTREDEKIN BESUDOTOX 58 PF # [002] 58 PSN# [002] 58 radiotherapeutic 58 Trizytek 58 rALLy 58 ZACTIMA 58 Qutenza TM 58 ReN# 58 PGL# 58 CG# [003] 58 Traficet EN 58 Desmoteplase 58 buccal spray 58 VEGF Trap 58 Dacogen decitabine 58 xanthine oxidase inhibitor 58 THALOMID 58 BLP# Liposome Vaccine 58 STEDESA 58 pitavastatin 58 Q#IR 58 Sebivo 58 Interferon alpha 58 Zenvia Phase III 58 Muraglitazar 58 Genasense R oblimersen 58 GAP #B# 58 orally inhaled migraine 58 QuadraSphere 58 IIb clinical trial 58 dalbavancin 58 Ixempra 58 Familial Adenomatous Polyposis FAP 58 AGHD 58 AVASTIN 58 vorinostat 58 OraTest 58 torezolid phosphate 58 Elagolix 58 Virulizin ® 58 Neo Kidney Augment 58 humanized monoclonal 58 aerosolized KL4 surfactant 58 clevidipine 58 eniluracil 58 vilazodone 58 plasma kallikrein inhibitor 58 ticagrelor Brilinta 58 SomatoKine 58 opioid induced bowel dysfunction 58 personalized immunotherapy 58 PROVENGE sipuleucel T 58 NS#/#A protease 58 ATL# [001] 58 Zelapar 58 EDEMA3 58 SYCREST 58 TACI Ig 58 Ancrod 58 Stedivaze 58 Annamycin 58 myelodysplastic myeloproliferative diseases 58 inhaled liposomal ciprofloxacin 58 pomalidomide 58 formerly LymphoStat B 58 Phase III ADT 58 randomized controlled Phase 58 AMEVIVE 58 GTC recombinant human 58 Hsp# Inhibitor 58 initiated Phase 1b 58 Cardica Microcutter XPRESS 58 APPRAISE 58 MKC# MT 58 orally dosed 58 hormone LHRH antagonist 58 Memryte 58 rhLF 58 HspE7 58 orphan medicinal product 58 riociguat 58 IMiDs R 58 SNT-MC#/idebenone 58 MoxDuo IR 58 PEG PAL 58 Onco TCS 58 pharmacokinetic PK 58 vinflunine 58 ABRAXANE ® 58 highly selective adenosine 58 RH1 58 LEP ETU 58 elotuzumab 58 Celgene Revlimid 58 TLR antagonists 58 ACZ# 58 metastatic hormone refractory 58 darinaparsin ZIO 58 ADVEXIN p# therapy 58 MBP# [001] 58 therapeutic monoclonal antibody 58 Serostim ® 58 APOPTONE 58 Granted Orphan Drug 58 RTP #i 58 Initiates Phase 2b 58 RhuDex R 58 Phase III randomized controlled 58 rALLy clinical trial 58 HP Acthar Gel repository 58 HepeX B TM 58 Deferiprone 58 Virulizin R 58 ATHX 58 ZYBRESTAT 58 GRNVAC1 57 CAELYX 57 nucleoside analog 57 recurrent metastatic 57 Rigel R# 57 chimeric monoclonal antibody 57 relapsed MM 57 investigational pan BCR 57 Nexavar tablets 57 Zavesca ® 57 novel emulsion formulation 57 MT#/MEDI-# 57 investigational hepatitis C 57 StaphVAX R 57 phase IIb III 57 NeuVax 57 pivotal bioequivalence 57 hPTH #-# 57 fidaxomicin Phase 57 PXD# 57 EGRIFTA TM 57 Arimoclomol 57 PCA3 test 57 Pivotal Trial 57 Neupro R 57 Phase #/#a 57 OncoVex 57 inhaled formulation 57 unoprostone isopropyl 57 DPP4 inhibitor 57 Mylotarg 57 Glufosfamide 57 favorable pharmacokinetic profile 57 INS# [001] 57 Orazol 57 Kevetrin ™ 57 Forodesine HCl 57 LymphoStat B 57 Uvidem 57 IAP inhibitor 57 novel peptide 57 Tasigna prolongs 57 SUCCEED trial 57 Silodosin 57 Medidur FA 57 Hematide ™ peginesatide 57 DPX Survivac 57 icatibant 57 Oncaspar 57 elacytarabine 57 DXL#